Precision Optics Inc Revenue Growth Rates (POCI), Current and Historic Growth - CSIMarket
CSIMarket
 


Precision Optics Corporation Inc   (NASDAQ: POCI)
 

POCI's Revenue Growth by Quarter and Year

Precision Optics Inc 's Revenue results by quarter and year




POCI Revenue (in millions $) FY 2025 FY 2024 FY 2023 FY 2022
4th Quarter June 8.77
3rd Quarter March 8.71
2nd Quarter December 7.37
1st Quarter September 6.68
FY 31.53

POCIs Annual Revenue
Precision Optics Inc 's Revenue in the fiscal year 2026 $ 31.53 millions
Precision Optics Inc 's Revenue in the fiscal year 2025 $ 19.09 millions
Precision Optics Inc 's Revenue in the fiscal year 2024 $ 19.10 millions
Precision Optics Inc 's Revenue in the fiscal year 2023 $ 21.04 millions
Precision Optics Inc 's Revenue in the fiscal year 2022 $ 15.68 millions




POCI Revenue fourth quarter 2025 Y/Y Growth Comment
Precision Optics Corporation Inc achieved in the fourth quarter 2025, above Company average Revenue rise of 41.98% year on year, to $ 8.77 millions.

Looking into fourth quarter 2025 results within Medical Equipment & Supplies industry 31 other companies have achieved higher Revenue growth. While Precision Optics Corporation Inc ' s Revenue jump of 41.98% ranks overall at the positon no. 554 in the fourth quarter 2025.




POCI Revenue ( Y/Y Growth %) 2025
2024 2023 2022
4th Quarter June 41.98 % 30.93 % -5.98 % 4.8 %
3rd Quarter March 107.88 % -20.04 % 3.76 % 8.6 %
2nd Quarter December 62.69 % -6.02 % -18.17 % 51.03 %
1st Quarter September 59.05 % -2.78 % -15.13 % 117.52 %
FY   65.1 % 0 % -9.26 % -

Financial Statements
Precision Optics Inc 's fourth quarter 2025 Revenue $ 8.77 millions POCI's Income Statement
Precision Optics Inc 's fourth quarter 2024 Revenue $ 6.18 millions Quarterly POCI's Income Statement


POCI Revenue (Quarter on Quarter Growth %)

2025
2024 2023 2022
4th Quarter June 0.74 % 47.49 % -9.92 % -0.59 %
3rd Quarter March 18.18 % -7.51 % 8.71 % -14.26 %
2nd Quarter December 10.33 % 7.86 % 11.57 % 15.72 %
1st Quarter September 8.09 % -11.02 % -13.94 % 6.26 %
FY (Year on Year)   65.1 % 0 % -9.26 % -




Revenue fourth quarter 2025 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #32
Healthcare Sector #130
Overall #554

Revenue Y/Y Growth Statistics
High Average Low
117.66 % 25.71 % -36.99 %
 
Revenue fourth quarter 2025 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #32
Healthcare Sector #130
Overall #554
Revenue Y/Y Growth Statistics
High Average Low
117.66 % 25.71 % -36.99 %
 

Revenue by Quarter for the Fiscal Years 2022, 2023, 2024, 2025

Precision Optics Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
98.6 % 6.67 % -36.28 %
(Jun 30 2018)  


POCI's IV. Quarter Q/Q Revenue Comment
Precision Optics Corporation Inc achieved in the IV. Quarter 2025 below company average Revenue growth of 0.74% quarter on quarter, to $ 8.77 millions.

Within Medical Equipment & Supplies industry 69 other companies have achieved higher Revenue quarter on quarter growth. While Precision Optics Inc 's Revenue growth quarter on quarter, overall rank is 1682.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #70
Healthcare Sector #225
Overall #1682
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #70
Healthcare Sector #225
Overall #1682
Revenue Q/Q Growth Statistics
High Average Low
98.6 % 6.67 % -36.28 %
(Jun 30 2018)  


POCI's IV. Quarter Q/Q Revenue Comment
Precision Optics Corporation Inc achieved in the IV. Quarter 2025 below company average Revenue growth of 0.74% quarter on quarter, to $ 8.77 millions.

Within Medical Equipment & Supplies industry 69 other companies have achieved higher Revenue quarter on quarter growth. While Precision Optics Inc 's Revenue growth quarter on quarter, overall rank is 1682.


Precision Optics Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Jun 30 2026)
12 Months Ending
(Mar 31 2026)
12 Months Ending
(Dec 31 2025)
12 Months Ending
(Sep 30 2025)
12 Months Ending
(Jun 30 2025)
Cumulative Revenue 12 Months Ending $ 31.53 $ 28.94 $ 24.42 $ 21.58 $ 19.09
Y / Y Revenue Growth (TTM) 65.16 % 64.18 % 30.69 % 13.67 % -0.07 %
Year on Year Revenue Growth Overall Ranking # 277 # 663 # 1078 # 2483 # 3181
Seqeuential Revenue Change (TTM) 8.96 % 18.52 % 13.17 % 13.01 % 8.31 %
Seq. Revenue Growth (TTM) Overall Ranking # 277 # 663 # 1078 # 2483 # 3181


Cumulative Revenue growth Comment
Precision Optics Inc saw improvement in Revenue growth trend, posting cumulative 12 months Revenue growth of 65.16% year on year, to $ 32 millions if the fiscal year would have ended in Jun 30 2026.
Precision Optics Inc 's trailing twelve months Revenue growth was higher than company's average 23.03% and higher than 64.18% growth in Mar 31 2026.
But from twelve months ended Mar 31 2026 rise was beneth at 8.96 % from $28.94 millions achieved in the period from Mar 31 2026 to Jun 30 2025.
We witness drop-off happening, more obvious observing the usual Q/Q TTM historic rise that is stronger at23.03%.
The momentum is even more impressive from twelve months ended Mar 31 2026 exhibited at 8.96 % increase from $28.94 millions in the period from Mar 31 2026 to Jun 30 2025.

In the Healthcare sector 378 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 277, from total ranking in previous quarter at 663.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 139
Healthcare Sector # 379
Overall # 2642

Revenue TTM Y/Y Growth Statistics
High Average Low
79.72 %
23.03 %
-19.46 %
(Sep 30 2022)  


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 104
Sector # 271
S&P 500 # 1700
Cumulative Revenue growth Comment
Precision Optics Inc saw improvement in Revenue growth trend, posting cumulative 12 months Revenue growth of 65.16% year on year, to $ 32 millions if the fiscal year would have ended in Jun 30 2026.
Precision Optics Inc 's trailing twelve months Revenue growth was higher than company's average 23.03% and higher than 64.18% growth in Mar 31 2026.
But from twelve months ended Mar 31 2026 rise was beneth at 8.96 % from $28.94 millions achieved in the period from Mar 31 2026 to Jun 30 2025.
We witness drop-off happening, more obvious observing the usual Q/Q TTM historic rise that is stronger at23.03%.
The momentum is even more impressive from twelve months ended Mar 31 2026 exhibited at 8.96 % increase from $28.94 millions in the period from Mar 31 2026 to Jun 30 2025.

In the Healthcare sector 378 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 277, from total ranking in previous quarter at 663.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 139
Healthcare Sector # 379
Overall # 2642

Revenue TTM Y/Y Growth Statistics
High Average Low
79.72 %
23.03 %
-19.46 %
(Sep 30 2022)  


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 104
Sector # 271
S&P 500 # 1700




Other Revenue Growth
Medical Equipment & Supplies Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
POCI's Revenue Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue growth for the quarter ending Jun 30 2026 within Healthcare SectorY/Y Change %Revenue for the quarter ending Jun 30 2026
Madrigal Pharmaceuticals Inc 71.17%$ 71.169 millions
Tg Therapeutics Inc 70.27%$ 70.272 millions
Tarsus Pharmaceuticals Inc 69.41%$ 69.406 millions
Hyperfine Inc 67.70%$ 67.698 millions
Alnylam Pharmaceuticals Inc 66.86%$ 66.856 millions
Emergent Biosolutions Inc 66.29%$ 66.288 millions
Vivos Therapeutics Inc 65.69%$ 65.691 millions
Iovance Biotherapeutics inc 65.65%$ 65.654 millions
Billiontoone Inc 64.40%$ 64.403 millions
Anteris Technologies Global Corp 63.27%$ 63.269 millions
Nexgel Inc 63.24%$ 63.242 millions
Carlsmed Inc 59.58%$ 59.575 millions
Sonoma Pharmaceuticals Inc 59.55%$ 59.552 millions
Arcutis Biotherapeutics Inc 59.33%$ 59.331 millions
Nephros Inc 58.55%$ 58.551 millions
Bioadaptives Inc 54.95%$ 54.955 millions
Zevra Therapeutics Inc 53.25%$ 53.251 millions
Beyond Air Inc 52.94%$ 52.941 millions
Caredx Inc 52.23%$ 52.226 millions
Bioxcel Therapeutics Inc 51.67%$ 51.667 millions
Glaukos Corp50.63%$ 50.628 millions
Heartflow Inc 49.80%$ 49.801 millions
Coya Therapeutics Inc 48.97%$ 48.974 millions
Travere Therapeutics Inc 48.17%$ 48.174 millions
Halozyme Therapeutics Inc 47.67%$ 47.673 millions
Eli Lilly And Company47.67%$ 47.670 millions
Rhythm Pharmaceuticals Inc 46.91%$ 46.911 millions
Axsome Therapeutics Inc 45.54%$ 45.543 millions
Guardant Health Inc 44.33%$ 44.332 millions
Omada Health Inc 43.27%$ 43.273 millions


About Precision Optics Inc Revenue Growth Rates (POCI), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Precision Optics Corporation Inc (CIK 867840).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001683168-26-007462
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Precision Optics Corporation Inc’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.